Global Blood Sugar Control Test Strips Market Growth 2024-2030

Global Blood Sugar Control Test Strips Market Growth 2024-2030

Blood sugar control test strips are a key component of blood glucose testing. These small disposable strips of plastic may look insignificant but they provide a very important role in helping people with diabetes to monitor and control their diabetes.

The global Blood Sugar Control Test Strips market size is projected to grow from US$ 12080 million in 2023 to US$ 18950 million in 2030; it is expected to grow at a CAGR of 6.6% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Blood Sugar Control Test Strips Industry Forecast” looks at past sales and reviews total world Blood Sugar Control Test Strips sales in 2023, providing a comprehensive analysis by region and market sector of projected Blood Sugar Control Test Strips sales for 2024 through 2030. With Blood Sugar Control Test Strips sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Sugar Control Test Strips industry.

This Insight Report provides a comprehensive analysis of the global Blood Sugar Control Test Strips landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood Sugar Control Test Strips portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood Sugar Control Test Strips market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Sugar Control Test Strips and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Sugar Control Test Strips.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment. Self-monitoring blood glucose (SMBG) devices, such as test strips, are used with a blood glucose meter to check for blood sugar irregularities and levels. Monitoring can help prevent diabetes hypoglycemia and other underlying medical conditions early. Diabetes is characterized by a blood glucose level of more than 200 mg/dL two hours after a meal. Diabetes prevalence has been increasing rapidly and is not limited to a specific age group. According to the International Diabetes Federation (IDF), approximately 537 million adults will be living with diabetes in 2021 and this is expected to increase to 643 million by 2030. The treatment and prevention of diabetes bring direct medical cost burden to patients. Rising prevalence of type 2 diabetes globally, growing number of diabetic and hypoglycemic patients, rising demand for home glucose monitoring systems and steady shift from venipuncture blood glucose testing to easy-to-use test kits are expected over the forecast period Some of the key factors driving the revenue growth of the market. Additionally, rising prevalence of diabetes-related diseases such as cardiovascular disease (CVD), neuropathy, and kidney disease, and growing awareness about the benefits of early disease detection and preventive measures are other factors driving the adoption of blood glucose test strips among diabetics.

This report presents a comprehensive overview, market shares, and growth opportunities of Blood Sugar Control Test Strips market by product type, application, key manufacturers and key regions and countries.

Segmentation by type


Glucose Dehydrogenase

Glucose Oxidase
Segmentation by application


Hospital

Home
This report also splits the market by region:


Americas
United States
Canada
Mexico
Brazil

APAC
China
Japan
Korea
Southeast Asia
India
Australia

Europe
Germany
France
UK
Italy
Russia

Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.


Roche

LifeScan

Abbott

Ascensia

ARKRAY

I-SENS

Omron

B. Braun

77 Elektronika

AgaMatrix

Terumo

Sinocare

Yicheng

Yuwell

Acon
Key Questions Addressed in this Report

What is the 10-year outlook for the global Blood Sugar Control Test Strips market?

What factors are driving Blood Sugar Control Test Strips market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Blood Sugar Control Test Strips market opportunities vary by end market size?

How does Blood Sugar Control Test Strips break out type, application?


Please note: The report will take approximately 2 business days to prepare and deliver.